Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled date : 2021 - 10 - 28 save search
Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology
Published: 2021-10-28 (Crawled : 20:00) - prnewswire.com
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.17%
H: 1.06%
C: 0.39%
ema phase 3 trial
Global Immunotherapy Drugs Markets 2021-2026 - Launch of NG Immunotherapies / COVID-19 as Growth Catalyst / Approval of Novel Immunotherapy Drugs / Surge in Adoption of Car T-Cell Therapies
Published: 2021-10-28 (Crawled : 18:00) - prnewswire.com
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
covid immunotherapy therapy drug growth approval t-cell car-t
Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
Published: 2021-10-28 (Crawled : 00:00) - prnewswire.com
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
INCY | $51.4 -0.48% 380K
|
Health Technology
|
| O: 0.49%
H: 1.01%
C: 0.69%
treatment china therapy collaboration cancer vaccine
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.